European Research Infrastructures, many of them organised as ERICs, are essential resource to the researchers studying the many aspects of the pandemics. Addressing issues such as development of the vaccine and medicines, insights into the social challenges, and the impact on environment, the ERICs support researchers to find solutions to the current crisis. Many of the ERICs have responded to the challenge at hand by setting up a dedicated service, which we are highlighted here.
Within the ERIC landscape, the following ERICs have set up or are currently planning various initiatives in response to the coronavirus outbreak:
- BBMRI-ERIC provides resources from biobanks across Europe. The network of 600+ biobanks presents a list of those BBMRI national nodes and biobanks that provided specific information on the resources they can make available to researchers (academic and from the private sector) working on COVID-19. (Details about the service here).
- CERIC-ERIC has set up a dedicated Fast Track access to a selected number of instruments to facilitate research related to COVID-19. Researchers can apply for the Fast Track without undergoing a regular evaluation procedure. If approved, the research project will be scheduled within a month from the submission of the proposal, based on the evaluation of the project’s feasibility by the facility where measurements will be performed.(Details about the service here).
- CLARIN-ERIC allows the analysis of large volumes of medical records and publications in textual format and detection of misinformation in mainstream and social media. (Details about the service here).
- DARIAH-ERIC maintains a set of registries essential for humanities research and brokers access to tools and services via its distributed structure and in-kind contribution model. This allows the long-term perspective on the social and cultural shifts from the COVID-19 pandemic. (Details about the service here).
- EATRIS-ERIC – Fast access to services and facilities: EATRIS provides key services for researchers and/or research teams (academic or industrial) that are developing a potential therapy, vaccine or tool for use against the current COVID-19 pandemic, with secured funding. Find here EATRIS Members’ COVID-19 activities and services. (Details about the service here).
- ECRIN-ERIC provides support and operational services to the planning, design and management of multinational clinical trials in Europe. (Details about the service here).
- Euro-BioImaging ERIC – Rapid access to data and resources related to imaging: Biological and biomedical imaging technologies are essential for addressing many of the research questions related to the virus, SARS-CoV-2, and the COVID-19 disease it induces, from fundamental research at the molecular and cellular level to medical applications and diagnostics.
- European Spallation Source DEMAX– Prioritised access: The Deuteration & Macromolecular Crystallisation (DEMAX) platform at ESS is offering prioritised access to laboratory services for scientists and researchers working on COVID-19-related research projects. It is able to provide expertise, advice and limited materials to support research aimed at the critical need to gain a better understanding of COVID-19. (Details about the service here).
- EU-OPENSCREEN’s partner sites are currently engaged in a range of activities to study the new coronavirus SARS-CoV-2 with focus on drug discovery including screening campaigns of local repurposing libraries. (Details about the service here).
- Infrafrontier offers specialised resources and emergency archiving of Mouse Models to aid essential research and preserve valuable strains.(Details about the service here).
- INSTRUCT-ERIC offers priority access to groups that need to use its structural biology services for projects directly related to COVID-19 viral proteins. Priority access will ensure a faster review of research proposals relating to COVID-19.(Details about the service here)
- LifeWatch-ERIC facilities allow research on epidemiology modelling; large scale data management (including Blockchain-based technologies).(Details about the service here).
- SHARE-ERIC contributes to research about the social, health and economic impact of COVID-19. Across 27 European countries and Israel, a special “SHARE Corona” questionnaire is currently being prepared, covering various research areas: Infection and Health, Mental health, Economic, Social Network, Healthcare. The data will offer researchers the possibility to measure and interpret differences in a cross-country and a longitudinal dimension.
Other sources about information related to COVID-19 and research infrastructures:
- The ERF page gathers detailed information about the COVID-19 dedicated activities of Research Infrastructures in Europe, open to the international research community.
- ESFRI has set a dedicated webpage containing information about ESFRI RIs, as well as national ones, for COVID-19 resources and activities.
- The European Life Science Research Infrastructures present details about their serverices here.